Luiz F. Zerbini
- Physiology top 1%
- Adenosine and Purinergic Signaling 9
- Cancer Research top 5%
- NF-κB Signaling Pathways 12
- Immunology top 5%
- Oncology top 5%
- Cytokine Signaling Pathways and Interactions 10
- Molecular Biology top 5%
- Ubiquitin and proteasome pathways 8
- Metabolomics and Mass Spectrometry Studies 7
-
- Prostate Cancer Treatment and Research 8
-
- Inflammatory mediators and NSAID effects 7
-
- Liver Disease Diagnosis and Treatment 7
- Co-authors
- Towia A. LibermannJuliano D. PaccezYihong WangRicardo G. CorreaJe‐Yoel ChoJaira F. de VasconcellosXuesong GuPaul B. Fisher
- Cited by
- PhysiologyCancer ResearchImmunology
- Journals
- Proceedings of the National Academy of Sciences (1 paper)Journal of Biological Chemistry (3 papers)SHILAP Revista de lepidopterología (2 papers)
- Partner nations
- South AfricaUnited StatesBrazil
In The Last Decade
Luiz F. Zerbini
92 papers receiving 3.3k citations
Peers
Comparison fields: 5 of 131
- Physiology 240
- Cancer Research 628
- Immunology 567
- Oncology 713
- Molecular Biology 1.6k
Countries citing papers authored by Luiz F. Zerbini
This map shows the geographic impact of Luiz F. Zerbini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luiz F. Zerbini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luiz F. Zerbini more than expected).
Fields of papers citing papers by Luiz F. Zerbini
This network shows the impact of papers produced by Luiz F. Zerbini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luiz F. Zerbini. The network helps show where Luiz F. Zerbini may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Luiz F. Zerbini, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2023 | 8 | |
| 5 | 2023 | 5 | |
| 6 | 2023 | 7 | |
| 7 | 2023 | 1 | |
| 8 | 2021 | 9 | |
| 9 | 2020 | 18 | |
| 10 | 2019 | 18 | |
| 11 | 2015 | 36 | |
| 12 | 2014 | 49 | |
| 13 | 2008 | 48 | |
| 14 | 2007 | 79 | |
| 15 | 2006 | 48 | |
| 16 | 2006 | 11 | |
| 17 | 2005 | 1 | |
| 18 | Constitutive activation of nuclear factor kappaB p50/p65 and Fra-1 and JunD is essential for deregulated interleukin 6 expression in prostate cancer. | 2003 | 145 |
| 19 | 2002 | 3 | |
| 20 | 1994 | 23 |
About Luiz F. Zerbini
Luiz F. Zerbini is a scholar working on Physiology, Cancer Research and Oncology, having authored 99 papers that have together received 3.3k indexed citations. Recurring topics across this work include NF-κB Signaling Pathways (12 papers), Cytokine Signaling Pathways and Interactions (10 papers), Adenosine and Purinergic Signaling (9 papers), Ubiquitin and proteasome pathways (8 papers), Prostate Cancer Treatment and Research (8 papers), Metabolomics and Mass Spectrometry Studies (7 papers), Inflammatory mediators and NSAID effects (7 papers) and Liver Disease Diagnosis and Treatment (7 papers). The work is most often cited by research in Physiology (240 citations), Cancer Research (628 citations) and Immunology (567 citations). Luiz F. Zerbini has collaborated with scholars based in South Africa, United States and Brazil. Frequent co-authors include Towia A. Libermann, Juliano D. Paccez, Yihong Wang, Ricardo G. Correa, Je‐Yoel Cho, Jaira F. de Vasconcellos, Xuesong Gu, Paul B. Fisher, Devanand Sarkar and Manoj Bhasin. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.